Intrapartum labetalol for the treatment of maternal and fetal thyrotoxicosis

Mary L. Bowman, Michele Bergmann, James Smith, Jr.

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Maternal thyrotoxicosis complicates approximately 0.2% of pregnancies. Simultaneous occurrence of maternal and fetal thyrotoxicosis during labor is rare, and control of maternal tachycardia and hypertension, as well as fetal manifestations of thyrotoxicosis, are cornerstones of management. An 18- year-old nulliparous female at 33 weeks gestational age presented in labor with thyrotoxicosis. Fetal tachycardia was present as well. Labetalol therapy resulted in a decrease in maternal pulse and blood pressure, and resolution of fetal tachycardia. Vaginal delivery occurred. Subsequent evaluation demonstrated neonatal thyrotoxicosis and high maternal titers of thyroid- stimulating immunoglobulin. In conclusion, labetalol was beneficial in the treatment of maternal and fetal thyrotoxicosis during labor.

Original languageEnglish
Pages (from-to)795-796
Number of pages2
JournalThyroid
Volume8
Issue number9
StatePublished - 1998

Fingerprint

Labetalol
Thyrotoxicosis
Mothers
Tachycardia
Thyroid-Stimulating Immunoglobulins
Blood Pressure
Gestational Age
Hypertension
Pregnancy

All Science Journal Classification (ASJC) codes

  • Endocrinology

Cite this

Intrapartum labetalol for the treatment of maternal and fetal thyrotoxicosis. / Bowman, Mary L.; Bergmann, Michele; Smith, Jr., James.

In: Thyroid, Vol. 8, No. 9, 1998, p. 795-796.

Research output: Contribution to journalArticle

Bowman, Mary L. ; Bergmann, Michele ; Smith, Jr., James. / Intrapartum labetalol for the treatment of maternal and fetal thyrotoxicosis. In: Thyroid. 1998 ; Vol. 8, No. 9. pp. 795-796.
@article{be30645fdd394984bf59edd590551ad1,
title = "Intrapartum labetalol for the treatment of maternal and fetal thyrotoxicosis",
abstract = "Maternal thyrotoxicosis complicates approximately 0.2{\%} of pregnancies. Simultaneous occurrence of maternal and fetal thyrotoxicosis during labor is rare, and control of maternal tachycardia and hypertension, as well as fetal manifestations of thyrotoxicosis, are cornerstones of management. An 18- year-old nulliparous female at 33 weeks gestational age presented in labor with thyrotoxicosis. Fetal tachycardia was present as well. Labetalol therapy resulted in a decrease in maternal pulse and blood pressure, and resolution of fetal tachycardia. Vaginal delivery occurred. Subsequent evaluation demonstrated neonatal thyrotoxicosis and high maternal titers of thyroid- stimulating immunoglobulin. In conclusion, labetalol was beneficial in the treatment of maternal and fetal thyrotoxicosis during labor.",
author = "Bowman, {Mary L.} and Michele Bergmann and {Smith, Jr.}, James",
year = "1998",
language = "English",
volume = "8",
pages = "795--796",
journal = "Thyroid",
issn = "1050-7256",
publisher = "Mary Ann Liebert Inc.",
number = "9",

}

TY - JOUR

T1 - Intrapartum labetalol for the treatment of maternal and fetal thyrotoxicosis

AU - Bowman, Mary L.

AU - Bergmann, Michele

AU - Smith, Jr., James

PY - 1998

Y1 - 1998

N2 - Maternal thyrotoxicosis complicates approximately 0.2% of pregnancies. Simultaneous occurrence of maternal and fetal thyrotoxicosis during labor is rare, and control of maternal tachycardia and hypertension, as well as fetal manifestations of thyrotoxicosis, are cornerstones of management. An 18- year-old nulliparous female at 33 weeks gestational age presented in labor with thyrotoxicosis. Fetal tachycardia was present as well. Labetalol therapy resulted in a decrease in maternal pulse and blood pressure, and resolution of fetal tachycardia. Vaginal delivery occurred. Subsequent evaluation demonstrated neonatal thyrotoxicosis and high maternal titers of thyroid- stimulating immunoglobulin. In conclusion, labetalol was beneficial in the treatment of maternal and fetal thyrotoxicosis during labor.

AB - Maternal thyrotoxicosis complicates approximately 0.2% of pregnancies. Simultaneous occurrence of maternal and fetal thyrotoxicosis during labor is rare, and control of maternal tachycardia and hypertension, as well as fetal manifestations of thyrotoxicosis, are cornerstones of management. An 18- year-old nulliparous female at 33 weeks gestational age presented in labor with thyrotoxicosis. Fetal tachycardia was present as well. Labetalol therapy resulted in a decrease in maternal pulse and blood pressure, and resolution of fetal tachycardia. Vaginal delivery occurred. Subsequent evaluation demonstrated neonatal thyrotoxicosis and high maternal titers of thyroid- stimulating immunoglobulin. In conclusion, labetalol was beneficial in the treatment of maternal and fetal thyrotoxicosis during labor.

UR - http://www.scopus.com/inward/record.url?scp=0031761629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031761629&partnerID=8YFLogxK

M3 - Article

VL - 8

SP - 795

EP - 796

JO - Thyroid

JF - Thyroid

SN - 1050-7256

IS - 9

ER -